DELAWARE, Sept 23 — AstraZeneca said today its experimental precision drug developed with Japan’s Daiichi Sankyo does not significantly improve overall survival for patients with a type of breast cancer in a late-stage trial.

KUALA LUMPUR, Dec 13 — Malaysian Genomics Resource Centre Bhd has ventured into the biopharmaceutical sector with the aim of improving cancer treatment options in the country.